29
CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Embed Size (px)

Citation preview

Page 1: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

CA125: More than Just a Biomarker

Manish S. Patankar, PhDUniversity of Wisconsin-Madison

Department of OB/GYNDivision of Gynecologic Oncology

Page 2: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

• What is CA125?

• Why is CA125 detected in the blood of cancer patients?

• Why do ovarian cancer cells produce CA125?

Page 3: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Ovarian Cancer Cell Under an Electron Microscope

27-30 micrometer

Page 4: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

How small are cancer cells?

Diameter of a penny is 19.05 millimeter or 19,050 micrometer

The diameter of a cancer cell is approximately 1/700th-1/600th of a penny

Page 5: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

TumorCancer cell Time

Diagnosis and treatment

Page 6: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Research at University of Wisconsin-Madison

• Understanding the biological role of CA125 in ovarian cancer

• Developing immunotherapeutic agents that target ovarian cancer

• Developing novel therapeutic agents that can inhibit the growth of cancer cells

Page 7: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Using Natural Killer Cells (NK) to target ovarian cancer

Cancer cell

NK

NK

Cell Death

Page 8: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Cancer cell

NK

NK cells attack cancer cells

Page 9: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Boosting the anti-cancer activity of NK cells

Cancer cell

NK

NK

• huKS-IL2

• Resveratrol

Page 10: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Boosting the anti-cancer activity of NK cells

Cancer cell

NK

• huKS-IL2: Increases the ability of NK cells to bind to cancer cells

• Resveratrol activates NK cells

Cell Death

Page 11: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

• Conjugated Linoleic acid (CLA)

• A constituent of milk and red meat

• CLA inhibits growth of ovarian cancer cells when tested under experimental conditions

New therapeutic agents

Page 12: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Research at University of Wisconsin-Madison

• Understanding the biological role of CA125 in ovarian cancer

• Developing immunotherapeutic agents that target ovarian cancer

• Developing novel therapeutic agents that can inhibit the growth of cancer cells

Page 13: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

What is CA125?CA125 is a tiny part of a very large molecule called MUC16

Ovarian Cancer cell

CA125

CA125

CA125

MUC16

Page 14: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

MUC16 Under an Electron Microscope

Mol. Wt= 3-10 million Da

1-2 mm in length

Courtesy of Dr. John Sheehan, U. North Carolina

Page 15: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Mo

lecu

lar

size

Hemoglobin Antibody MUC16

Page 16: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Why is CA125 Detected in the Blood?

Ovarian Cancer cell

CA125

CA125

CA125

Page 17: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Why is CA125 Detected in the Blood?

Ovarian Cancer cell

CA125

CA125

CA125

Blood

Page 18: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Serum CA125 Assay

CA125

Page 19: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

• CA125 is not useful for early detection of ovarian cancer

• Used only for follow-up

• Study from an European trial (MRC OV05/EORTC 55955) suggest that early treatment of recurrent cancer determined by rise in CA125 does not result in benefit in survival of patients

Page 20: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Ovarian Cancer cell

CA125

CA125

CA125

Importance of MUC16 (CA125) in Ovarian Cancer

Cell Death

Page 21: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Ovarian Cancer cell

CA125

CA125

CA125

Importance of MUC16 (CA125) in Ovarian Cancer

No Cell Death

Page 22: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Ovarian Cancer cell

Importance of MUC16 (CA125) in Ovarian Cancer

Cell Death

NK

NK

Page 23: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

MUC16 Protects Ovarian Cancer Cells from NK cells

Ovarian Cancer

Ovarian Cancer

NK

NK

Page 24: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

MUC16low MUC16medium MUC16high

NK cells selectively target csMUC16low cells

csMUC16low csMUC16medium csMUC16high0

10

20

30

40

Nu

mb

er o

f co

nju

gat

es

Page 25: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

MUC16 binds to NK cells

NK

Ovarian Cancer cell

NK

Blood vessel

Page 26: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Loss of MUC16 Increases Survival of Ovarian Cancer Bearing Mice

0 50 100 150 200 250 3000

102030405060708090

100110

MUC16 neg -OVCMUC16 pos -OVC

Days

Per

cen

t su

rviv

al

Page 27: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Introduce agents that inhibit production of MUC16 (CA125)

OvarianTumor

Decrease in MUC16 (CA125) will

• Induce cancer cell death

• Disarm the cells and allow targeting by NK cells

Introduce NK cells to target tumors

Page 28: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology

Our Team

• Dr. Arvinder Kapur, Dr. Rebecca Whelan, Mildred Felder, Kai Ludwig, Soma Banerjee, and Yang Liu

• Drs. David Kushner, Ellen Hartenbach, Laurel Rice, Steve Rose, Ahmed Al-Niami

• Drs. Nonyem Onujiogu, Mian Shahzad, Shitanshu Uppal

• Drs. Paul Sondel, Paul Campagnola, Pamela Kreeger, Arthur Polans, and Irwin Goldman

Page 29: CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology